Get started

BIOCON

Short BioconI hope you can now see how the Biocon represents an excellent low risk profit entry setup allowing you to trade in the market.Take positions so that the risk/reward is in your favour. Knowing why, where & when a strong reversal signal is being generated will be the only way to capitalize on your technical analysis . Disclaimer: It should not be assumed that the methods, techniques, or indicators presented in these chart will be profitable or that they will not result in losses. There is no assurance that the strategies and methods presented will be successful for you. Past results are not necessarily indicative of future results. You should not trade with money that you cannot afford to lose. Examples presented in these products are for educational purposes only and it should not be assumed that these are indicative of ordinary trades. These setups are not solicitations of any order to buy or sell. The publisher assume no responsibility for your trading results. There is a high degree of risk in trading.
NSE:BIOCONShort
by EntryandExit
Analysis of Biocon Limited.Update Dt. – 11-07-2020 Price is a trap between the triangular pattern and the share is near an all-time high. On 10-07-2020 the share made the all-time high of ₹420.5 and closed at ₹414.3. Price is also taking the support of 21DEMA and 50DEMA also indicates the uptrend. From 1st week of June, the share price was in consolidation form ranging between 380 to 400 and recently on 09-07-2020 it gave closing above ₹400 thus coming out of consolidation process. We can conclude from this that share can give breakout in a few days as not only price but volume is in support too.
NSE:BIOCONLong
by mr-sky
NIFTY Outlook for Wednesday, 15th July | 50x InvestmentsNIFTY - Technical Analysis: On the daily chart Nifty broke into the previous wedge after giving a failed breakout There was a big OI build up for weekly call options at 10700 strike, indicating that writers are confident that Nifty won't cross 10,700 levels in the next 2 days MACD entered negative levels, giving out a strong sell signal NIFTY - Driving Factors: The hangover of poor TCS numbers is still being felt in the IT space Banks and NBFCs reeling under the pressure of potential rise in NPAs, Bank Nifty was down by over 3% today Biocon was the shining star in today's trade, rising almost 5.2% because of their new drug announcement to treat severe COVID cases NIFTY - Outlook for Tomorrow, 15th July: A failed breakout of a wedge usually leads to test of the lower trend-line and might even go all the way down to the start of the trend if the bearish pressure continues 10,544 (lower trend-line) and 10,390 (23.6% retracement level) will be crucial support levels Infosys is set to announce its Q1 FY21 results tomorrow. If TCS's earnings are anything to go by, Infosys' results might further add to the bearish pressure.
NSE:NIFTYShort
by Algokart
Biocon Stock to take the short entry.In Daily chart we have seen the shooting star candle at the Resist.level to take the short entry. Short entry can be taken below the level of 400 as we can see strong support at this level. Let's wait to BD this level. After 395 once stock move below the 20 EMA level then we can see the 390 level in the stock. So add the stock in your watch list to see the further price action movement in the share. Always do trading as per your Reward to Risk ratio means Never risk more than you can afford to lose on a single trade. Please keep patience & wait for the levels means Sit and wait for the right opportunity. Request to like & follow for more such ideas of technical analysis learning.The idea sharing is for educational purpose only. In case any suggestion advice required feel free to ask .
NSE:BIOCONShort
by Tech_stock_trader
1
Biocon - Past view and current DilemmaBiocon - It always had long consolidated years and the only big move since beginning was from 79rs to 200+ was way back 4 years ago. A significant 200% up in 2-3years. More often than not, the price consolidation periods were longer than that of the up runs the stock had. At curent levels, the volume candle of this week is shorter than that of the previous week, which in my view signifies a hesitation from traders to increase the price action. This has also resuted in some profit booking. Given that the market for Pharma is in the uprise, there were more than few companies which hit their new 52 week highs, beating their relative previous highs again and again. Biocon stands as an exception here, as it did not capitulate on the Pharma uprise trend. However, given that the earnings grew year on year 3.41% up and net sales standing rs 1581 cr, OI being almost close to 3.8% up AVG, if it manages to close above 375 in the upcoming week, the stock may see levels of 390-428. To conclude, Biocon may not see a speed up in its price action and once it reaches the 428 level, we may further see another consolidation period, unless there is surprise element in store, with regards to earnings for next quarter and the next. View: Can go long with a stop loss of 310. 1-1.5 years which it may take to see 35-45% returns. Note: Views are personal and meant for education purpose only. I highly appreciate your comments, views or any efforts you put towards sharing knowledge on markets.
BSE:BIOCONLong
by kalyanbharathp
1